TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2023 Earnings Call Transcript November 6, 2023 4:30 PM ET

Company Participants

Brian Johnston - Gilmartin Group

Waleed Hassanein - President and CEO

Stephen Gordon - CFO

Conference Call Participants

Allen Gong - JPMorgan

Bill Plovanic - Canaccord

Suraj Kalia - Oppenheimer

Ryan Daniels - William Blair

Josh Jennings - TD Cowen

Operator

Good afternoon, and welcome to TransMedics Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end today's call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Brian Johnston from the Gilmartin Group for a few introductory comments.

Brian Johnston

Thank you. Earlier today TransMedics released financial results for the quarter ended September 30th, 2023. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that, management will make statements during this call, including during the question-and-answer portion of the call that include forward-looking statements within the meaning of Federal Securities laws. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.

All forward-looking statements including without limitation, are examination of operating trends, the potential commercial opportunity for our products, and our future financial expectations, which include expectations for growth in our organization and guidance and or expectations for revenue, gross margins, and operating expenses in 2023 and beyond are based upon our current assumptions and estimates. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.

Additional information regarding these risks and uncertainties appears under the heading Risk Factors on our Form 10-K filed with the Securities and Exchange Commission on February 27th, 2023, our subsequent form 10-Q filings and the forward-looking statements included in today's press release which is available at our website and at www.sec.gov.

TransMedics disclaims any intention or obligation, except as required by law to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast today November 6th, 2023.